What does the CBD down-scheduling mean?

Description

...the Therapeutic Goods Administration (TGA) has indicated that it will, indeed, adopt a more open attitude – at least towards low-dose cannabidiol, the non-psychoactive component of cannabis which, according to the limited data available, provides relief from anxiety, insomnia and pain.

By down-scheduling low-dose CBD – classified as 60 mg per day – to a schedule 3 medicine, it will, from June 2021, become available over the counter at pharmacies, without a prescription. Confirmation of September’s interim decision to down-schedule is expected later this month.

Yet beneath the simplistic CBD-for-all headlines that greeted the TGA’s announcement is a more uncertain and nuanced picture. For starters, there are serious question marks about the efficacy of CBD at such a low dose, something recognised in a TGA Safety Review.

Subject

Cannabis

Therapeutic Goods Administration